loader image
Sunday, December 21, 2025
71.2 F
McAllen
- Advertisement -

How does hormone therapy affect cardiovascular health, insulin resistance?

Translate to Spanish or other 102 languages!

How does hormone therapy affect heart and metabolic health? Image for illustration purposes
How does hormone therapy affect heart and metabolic health? Image for illustration purposes

Medical News Today

- Advertisement -
  • Research presented at the 2024 Annual Meeting of The Menopause Society in Chicago has aimed to uncover the impact of hormone replacement therapy on various aspects of health.
  • One study reports that extended use of some hormone therapies can improve markers of cardiovascular health at menopause.
  • A large meta-analysis further found that hormone therapy can help improve insulin sensitivity by restoring estrogen levels.

Hormone replacement therapy (HRT) is a widespread treatment for a range of menopause symptoms, such as hot flashes, night sweats, and vaginal dryness.

Follow the link below to read he full story on Medical News Today:

https://www.medicalnewstoday.com/articles/menopause-hormone-therapy-improve-heart-health-insulin-resistance?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-09-30&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.

Early Findings Show Breast Cancer Vaccine Produces Immune Response

Cleveland Clinic released its findings from the first phase of the clinical trial for the preventive breast cancer vaccine. 
- Advertisement -
×